MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 377 filers reported holding MEDIVATION INC in Q1 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $2,897,000 | +113.8% | 59,919 | +405.3% | 0.48% | +157.3% |
| Q2 2015 | $1,355,000 | -66.1% | 11,859 | -61.7% | 0.18% | -61.9% |
| Q1 2015 | $4,001,000 | +24.6% | 30,999 | -4.5% | 0.48% | -2.8% |
| Q3 2014 | $3,211,000 | +641.6% | 32,466 | +476.9% | 0.50% | +667.7% |
| Q2 2014 | $433,000 | +12.5% | 5,628 | -28.0% | 0.06% | -16.7% |
| Q2 2013 | $385,000 | – | 7,821 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 4,397,838 | $186,908,000 | 79.34% |
| Redmile Group, LLC | 1,752,642 | $74,487,000 | 5.64% |
| APIS CAPITAL ADVISORS, LLC | 93,500 | $3,974,000 | 5.50% |
| March Altus Capital Management LP | 18,794 | $799,000 | 4.71% |
| HealthCor Management, L.P. | 1,900,000 | $80,750,000 | 4.55% |
| BB BIOTECH AG | 2,581,112 | $109,697,000 | 3.48% |
| Selkirk Management LLC | 116,000 | $4,930,000 | 3.06% |
| Opus Point Partners Management, LLC | 118,372 | $5,031,000 | 2.78% |
| TORRAY INVESTMENT PARTNERS LLC | 797,015 | $33,873,000 | 2.49% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 3,772,600 | $160,336,000 | 1.78% |